A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix

Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms

(2009) Enrico Ruffini et al.   ANNALS OF THORACIC SURGERY

Regulatory (FOXP3+) T cells as target for immune therapy of cervical intraepithelial neoplasia and cervical cancer

(2009) Christoph Loddenkemper et al.   CANCER SCIENCE

The Prevalence of Human Papillomavirus Type 58 in Chinese Patients with Cervical Carcinoma and its Influence on Survival

(2009) Walayat Shah et al.   CLINICAL ONCOLOGY

Host immune responses to cervical cancer

(2009) Swati Patel et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Critical role for CD8+FoxP3+ regulatory T cells in colon cancer immune response in humans

(2009) I. Sobhani et al.   GUT

Use of tumour-responsive T cells as cancer treatment

(2009) Mary L Disis et al.   LANCET

Infiltrating regulatory T cell numbers is not a factor to predict patient's survival in oesophageal squamous cell carcinoma

(2008) T Yoshioka et al.   BRITISH JOURNAL OF CANCER

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer

(2008) Ninke Leffers et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

(2008) Paul Salama et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis

(2008) Na-Ri Lee et al.   LEUKEMIA & LYMPHOMA

Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma

(2007) A. Sasaki et al.   EJSO

Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma

(2007) Markéta Tomšová et al.   GYNECOLOGIC ONCOLOGY